# Early Cardiac Manifestations as the Initial Presentation of Duchenne Muscular Dystrophy in Infancy

**Authors:** Feras Shatarat, Jana Alkasasbeh, Rahaf Shatarat, Sofian Tarawneh

PMC · DOI: 10.7759/cureus.101855 · Cureus · 2026-01-19

## TL;DR

A male infant showed early heart issues before typical Duchenne muscular dystrophy symptoms, highlighting the need for cardiac evaluation in cases of unexplained elevated creatine kinase.

## Contribution

This case report highlights an unusual early cardiac presentation of DMD in infancy, emphasizing the importance of cardiac assessment in infants with persistently elevated CK levels.

## Key findings

- An infant with Duchenne muscular dystrophy showed cardiac abnormalities at 12 months before neuromuscular symptoms.
- Persistent elevated creatine kinase levels prompted further evaluation leading to DMD diagnosis.
- Early cardiac assessment is clinically important even when neurological exams appear normal.

## Abstract

Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disorder most commonly diagnosed between four and five years of age, while diagnosis during infancy remains uncommon due to initially normal neurological examinations and delayed onset of motor weakness. Although dystrophin deficiency affects cardiac muscle from birth, clinically apparent cardiac involvement is generally considered a later manifestation, rendering echocardiographically evident structural cardiac abnormalities during infancy rare.

We report a male infant with normal early motor development who initially presented at nine months of age with fever, dark urine, elevated transaminases, and markedly increased serum creatine kinase (CK) levels, which were initially attributed to hemolysis and presumed as viral myositis in the context of glucose-6-phosphate dehydrogenase deficiency. CK levels remained persistently elevated, prompting further evaluation. At 12 months of age, neurological examination was normal; however, cardiac assessment revealed mild left ventricular dilatation with preserved systolic function on echocardiography and electrocardiographic features consistent with left ventricular hypertrophy. Genetic testing subsequently confirmed an out-of-frame exon 44 deletion consistent with Duchenne muscular dystrophy. Motor stagnation became apparent by 15 months of age, while serial echocardiographic assessments demonstrated persistent but stable left ventricular dilatation.

This case illustrates an early cardiac presentation of Duchenne muscular dystrophy in which structural cardiac abnormalities preceded overt neuromuscular manifestations. In infants presenting with persistent elevation of serum creatine kinase beyond the expected recovery period of intercurrent illness, further evaluation, including early cardiac assessment, may be clinically important, even when neurological examination and early motor development appear normal.

## Linked entities

- **Diseases:** Duchenne muscular dystrophy (MONDO:0010679), viral myositis (MONDO:0016126)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, DMD (dystrophin) [NCBI Gene 1756] {aka BMD, CMD3B, DXS142, DXS164, DXS206, DXS230}
- **Diseases:** myositis (MESH:D009220), cardiomyopathy (MESH:D009202), ventricular enlargement (MESH:D006332), cardiac remodeling (MESH:D020257), muscle injury (MESH:D009135), cardiac involvement (MESH:D006331), ventricular dilatation (MESH:C566255), structural abnormalities (MESH:C566527), muscle degeneration (MESH:D009410), left ventricular abnormalities (MESH:D018487), X-linked muscular dystrophy (MESH:C564439), heart failure (MESH:D006333), falls (MESH:C537863), calcium dysregulation (MESH:D002128), tricuspid and pulmonary regurgitation (MESH:D014262), pericardial effusion (MESH:D010490), impaired systolic function (MESH:D003072), hemolysis (MESH:D006461), neurological deficits (MESH:D009461), DMD (MESH:D020388), clinical (MESH:D000075902), cardiac abnormalities (MESH:D018376), inherited myopathy (MESH:D030342), febrile illness (MESH:D005334), X-linked neuromuscular disorder (MESH:D009468), developmental delay (MESH:D002658), maternal (MESH:D000079262), neonatal jaundice (MESH:D007567), left ventricular hypertrophy (MESH:D017379), hyperCKemia (OMIM:123320), G6PD deficiency (MESH:D005955), viral myositis (MESH:D014777), left ventricular dilatation (MESH:C565277), myocardial fibrosis (MESH:D005355), loss of endurance (MESH:D016388), microvascular injury (MESH:D017566), muscle enzyme abnormalities (MESH:D000014), swallowing difficulty (MESH:D003680), dehydration (MESH:D003681), myocardial involvement (MESH:C564676), speech delay (MESH:D007805), motor delay (MESH:D006968), dilated cardiomyopathy (MESH:D002311), motor weakness (MESH:D018908), post-infectious muscle injury (MESH:D000094025), COVID-19 infection (MESH:D000086382)
- **Chemicals:** prednisolone (MESH:D011239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916021/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12916021/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916021/full.md

---
Source: https://tomesphere.com/paper/PMC12916021